Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53. (Record no. 19290904)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02385 a2200673 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515193935.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200912s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1460-2105 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1093/jnci/djp355 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Van Maerken, Tom |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20091202 |
245 00 - TITLE STATEMENT | |
Title | Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Journal of the National Cancer Institute |
Date of publication, distribution, etc. | Nov 2009 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1562-74 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Administration, Oral |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Animals |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Caspase 3 |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Caspase 7 |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Cycle |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Line, Tumor |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | DNA Fragmentation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Diploidy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Resistance, Neoplasm |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gene Expression Regulation, Neoplastic |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Imidazoles |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Immunoblotting |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Immunohistochemistry |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice, Nude |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mutation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neuroblastoma |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Piperazines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Proto-Oncogene Proteins c-mdm2 |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Reverse Transcriptase Polymerase Chain Reaction |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Transplantation, Heterologous |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Tumor Suppressor Protein p53 |
General subdivision | drug effects |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ferdinande, Liesbeth |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Taildeman, Jasmien |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lambertz, Irina |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Yigit, Nurten |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Vercruysse, Liesbeth |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rihani, Ali |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Michaelis, Martin |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cinatl, Jindrich |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cuvelier, Claude A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Marine, Jean-Christophe |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | De Paepe, Anne |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bracke, Marc |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Speleman, Frank |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Vandesompele, Jo |
773 0# - HOST ITEM ENTRY | |
Title | Journal of the National Cancer Institute |
Related parts | vol. 101 |
-- | no. 22 |
-- | p. 1562-74 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1093/jnci/djp355">https://doi.org/10.1093/jnci/djp355</a> |
Public note | Available from publisher's website |
No items available.